Literature DB >> 23381559

Metabolic bone diseases: Building bone is best in glucocorticoid-induced osteoporosis.

David Killock.   

Abstract

Entities:  

Year:  2013        PMID: 23381559     DOI: 10.1038/nrrheum.2013.16

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN: 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  1 in total

1.  Comparative effects of teriparatide and risedronate in glucocorticoid-induced osteoporosis in men: 18-month results of the EuroGIOPs trial.

Authors:  Claus-C Glüer; Fernando Marin; Johann D Ringe; Federico Hawkins; Rüdiger Möricke; Nikolaos Papaioannu; Parvis Farahmand; Salvatore Minisola; Guillermo Martínez; Joan M Nolla; Christopher Niedhart; Nuria Guañabens; Ranuccio Nuti; Emilio Martín-Mola; Friederike Thomasius; Georgios Kapetanos; Jaime Peña; Christian Graeff; Helmut Petto; Beatriz Sanz; Andreas Reisinger; Philippe K Zysset
Journal:  J Bone Miner Res       Date:  2013-06       Impact factor: 6.741

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.